5.40 USD
▼-0.15-2.62%
盘后 6.20 0.00%
2026-11-20
市值
$523.74M
市盈率
—
EPS
-1.37
股息率
—
52 周区间
2.74 – 8.09
成交量
654.29K
Beta
1.61
目标价
5.90
52W 低 2.7452W 高 8.09
价格走势
公司简介
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. It offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic, a...